Related Experiment Videos

[Balanced facial hydrophilicity of ioversol: a qualitative approach of hydrophilicity]

D Meyer1, B Bonnemain, M Dugast-Zrihen

  • 1Laboratoire Guerbet, Aulnay-Sous-Bois.

Annales De Radiologie
|January 1, 1992
PubMed

Insights

Iodinated contrast media toxicity stems from hydrophobic interactions. Evenly distributed facial hydrophilicity in molecules like ioversol can improve biocompatibility by shielding lipophilic areas.

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Biocompatibility

Background:

  • Chimiotoxicity of iodinated contrast media is linked to non-specific hydrophobic interactions with biological molecules.
  • Molecular lipophilicity and the accessibility of lipophilic areas influence these interactions.
  • Current lipophilicity measurements need enhancement with 3D structural data for better biocompatibility prediction.

Purpose of the Study:

  • To explore the concept of evenly distributed facial hydrophilicity for improving contrast media biocompatibility.
  • To investigate how molecular structure influences the spatial accessibility of lipophilic areas.
  • To provide a framework for designing safer polyiodinated contrast media.

Main Methods:

  • Analysis of molecular structures of iodinated contrast media.
  • Evaluation of lipophilicity using partition coefficients.
  • Assessment of the spatial localization of hydrophilic groups on the 1,3,5-triiodobenzene core.
  • Concept application to the molecular structure of ioversol.

Main Results:

  • Hydrophobic interactions are a key factor in contrast media chimiotoxicity.
  • Evenly distributed facial hydrophilicity can minimize access to lipophilic molecular regions.
  • The tertiary anilide group in ioversol facilitates facial hydrophilic protection by positioning hydroxyl groups on each face of the benzene ring.

Conclusions:

  • Improving biocompatibility of iodinated contrast media requires understanding the 3D localization of hydrophilic groups.
  • The concept of evenly distributed facial hydrophilicity, exemplified by ioversol, offers a strategy to reduce chimiotoxicity.
  • Designing contrast agents with enhanced facial hydrophilic protection is crucial for safer clinical applications.

Related Concept Videos